🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Early Stage Non-Small Cell Lung Cancer

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer NCT07034326Phase 2, Phase 31 site📍 Tianjin Kong Fanming · Tests: Electroacupuncture combined with immunotherapy, Zilongjin tablet combined with immunotherapy, Immunotherapy Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer NCT05292521NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Best Practice, Informational Intervention, Questionnaire Administration Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field NCT04944563NA1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Segmentectomy, Lobectomy Multiomics Tumor Evolution Model of NSCLC NCT05352035n/a1 site📍 Beijing Peking University People's Hospital Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases NCT06542159Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Online adaptive SBRT, Conventional SBRT Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer NCT06743581NA2 sites📍 Montreal📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Cemiplimab, Dupilumab Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Lung Cancer NCT07412327NA1 site📍 Guangzhou Guangzhou Concord Cancer Center · Tests: Stereotactic Body Proton Therapy A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery NCT07182682Phase 349 sites📍 Beijing📍 Beijing📍 Beijing Dizal (Jiangsu) Pharmaceutical Co., Ltd. · Tests: sunvozertinib, Matching Placebo MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer NCT05974475n/a2 sites📍 Milan📍 Milan European Institute of Oncology · Tests: SBRT, Surgery The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523NA4 sites📍 Abington📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Pulmonary Artery-First Surgical Technique, Biospecimen Collection Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer NCT02570815Phase 11 site📍 Hamilton St. Joseph's Healthcare Hamilton · Tests: indocyanine green ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007) NCT03786003NA1 site📍 Shanghai Fudan University · Tests: VATS, Thoracotomy Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) NCT04585477Phase 21 site📍 Stanford Stanford University · Tests: AVENIO ctDNA Surveillance Kit, Durvalumab, Durvalumab (Imfinzi) alone or in combination with platinum-based chemotherapy Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer NCT07432802NA4 sites📍 Copenhagen📍 Aalborg📍 Aarhus N Aarhus University Hospital · Tests: Stereotactic radiation therapy intervention, Surgical intervention To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer NCT07195084NA1 site📍 Hefei Anhui Provincial Cancer Hospital · Tests: Hypervision proton surgery A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced NCT06467383n/a25 sites📍 San Giovanni Rotondo📍 Brescia📍 Campobasso MSD Italia S.r.l. Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC NCT06088771Phase 1, Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Dupilumab, Cemiplimab A Study of Ivonescimab in People With Non-Small Cell Lung Cancer NCT07594522Phase 1, Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Photon or Proton standard stereotactic body radiotherapy (SBRT), Ivonescimab A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. NCT06284317Phase 342 sites📍 Camperdown📍 Penrith📍 St Leonards ETOP IBCSG Partners Foundation · Tests: Adjuvant durvalumab Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study NCT07042724NA1 site📍 Verona Universita di Verona · Tests: Physical exercise and nutrition intervention for the neoadjuvant setting, Physical exercise and nutrition for the adjuv… Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer NCT06737107n/a4 sites📍 Rozzano📍 Milan📍 Milan Scientific Institute San Raffaele Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations NCT07195695Phase 3202 sites📍 Fresno📍 Glendale📍 Orange Boehringer Ingelheim · Tests: Zongertinib, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer NCT03706027NA1 site📍 Rochester University of Rochester · Tests: radiation therapy-3 fractions, Radiation therapy-5 fractions Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer NCT05061550Phase 297 sites📍 Little Rock📍 Los Angeles📍 Oakland AstraZeneca · Tests: Durvalumab, Oleclumab, Monalizumab, Dato-DXd, AZD0171 Synapse 3D With Intravascular Indocyanine Green NCT03953144Phase 1, Phase 21 site📍 Hamilton St. Joseph's Healthcare Hamilton · Tests: Synapse 3D Lung Modelling, IC-Green (ICG) IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE) NCT05742607Phase 230 sites📍 St. Petersburg📍 Tampa📍 Chicago Innate Pharma · Tests: IPH5201 + durvalumab + standard chemotherapy Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients NCT07242547Phase 220 sites📍 Albacete📍 Alicante📍 Elche Fundación GECP · Tests: Tarlatamab Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer NCT05613452Phase 21 site📍 Shanghai Shanghai Proton and Heavy Ion Center · Tests: Carbon ion beam radiotherapy Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung Cancer NCT06730295Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Online adaptive SBRT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy